Investigational Drug Information for SM04690
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for SM04690?
SM04690 is an investigational drug.
There have been 11 clinical trials for SM04690.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 25th 2020.
The most common disease conditions in clinical trials are Osteoarthritis, Osteoarthritis, Knee, and Intervertebral Disc Degeneration. The leading clinical trial sponsors are Biosplice Therapeutics, Inc., Samumed LLC, and [disabled in preview].
There are ten US patents protecting this investigational drug and ninety-three international patents.
Summary for SM04690
| US Patents | 10 |
| International Patents | 93 |
| US Patent Applications | 32 |
| WIPO Patent Applications | 12 |
| Japanese Patent Applications | 6 |
| Clinical Trial Progress | Phase 3 (2020-08-25) |
| Vendors | 25 |
Recent Clinical Trials for SM04690
| Title | Sponsor | Phase |
|---|---|---|
| 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee | Biosplice Therapeutics, Inc. | Phase 3 |
| Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers | Biosplice Therapeutics, Inc. | Phase 1 |
| Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers | Samumed LLC | Phase 1 |
Clinical Trial Summary for SM04690
Top disease conditions for SM04690
Top clinical trial sponsors for SM04690
US Patents for SM04690
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| SM04690 | See Plans and Pricing | Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo [4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide | Samumed, LLC (San Diego, CA) | See Plans and Pricing |
| SM04690 | See Plans and Pricing | Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof | Samumed, LLC (San Diego, CA) | See Plans and Pricing |
| SM04690 | See Plans and Pricing | Treatment of osteoarthritis | Samumed, LLC (San Diego, CA) | See Plans and Pricing |
| SM04690 | See Plans and Pricing | Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-C]pyridin-2-yl)-1H-indazol-5-y- l)pyridin-3-yl)-3-methylbutanamide | Samumed, LLC (San Diego, CA) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for SM04690
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| SM04690 | Australia | AU2017274350 | 2036-06-01 | See Plans and Pricing |
| SM04690 | Brazil | BR112018074725 | 2036-06-01 | See Plans and Pricing |
| SM04690 | Canada | CA3026076 | 2036-06-01 | See Plans and Pricing |
| SM04690 | Chile | CL2018003423 | 2036-06-01 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
